Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pangaea Connectivity Technology Limited Interim / Quarterly Report 2022

Nov 30, 2021

49946_rns_2021-11-30_5f08f68a-1ad2-4d47-a149-6868dda80630.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

CONTENTS

CORPORATE INFORMATION 2
MANAGEMENT DISCUSSION AND ANALYSIS 4
OTHER INFORMATION 14
CONDENSED CONSOLIDATED STATEMENT OF PROFIT AND LOSS 23
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 24
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION 25
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 27
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS 28
NOTES TO INTERIM FINANCIAL STATEMENTS 31

CORPORATE INFORMATION

BOARD OF DIRECTORS

Executive Directors

Mr. Fung Yui Kong (馮銳江) Dr. Wong Wai Kong (黃偉桄) Ms. Leung Kwan Sin Rita (梁筠倩)

Non-Executive Director

Mr. Kam, Eddie Shing Cheuk (甘承倬)

Independent Non-Executive Directors

Mr. Chan Hiu Fung Nicholas (陳曉峰) Mr. Ling Kwok Fai Joseph (凌國輝) Mr. Sze Wing Chun (施永進)

AUDIT COMMITTEE

Mr. Sze Wing Chun (施永進) (Chairman) Mr. Kam, Eddie Shing Cheuk (甘承倬) Mr. Ling Kwok Fai Joseph (凌國輝)

REMUNERATION COMMITTEE

Mr. Ling Kwok Fai Joseph (凌國輝) (Chairman) Ms. Leung Kwan Sin Rita (梁筠倩) Mr. Sze Wing Chun (施永進)

NOMINATION COMMITTEE

Mr. Chan Hiu Fung Nicholas (陳曉峰) (Chairman) Mr. Fung Yui Kong (馮銳江) Mr. Ling Kwok Fai Joseph (凌國輝)

RISK MANAGEMENT COMMITTEE

Mr. Fung Yui Kong (馮銳江) (Chairman) Dr. Wong Wai Kong (黃偉桄) Ms. Leung Kwan Sin Rita (梁筠倩)

COMPANY SECRETARY

Mr. Ng Yuet Kong (吳乙江)

AUDITOR

Ernst & Young Certified Public Accountants Registered Public Interest Entity Auditor

COMPLIANCE ADVISER

Honestum International Limited

REGISTERED OFFICE

Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands

CORPORATE INFORMATION

COMPANY WEBSITE

www.pangaea.com.hk

HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG

Rooms 902–6, 9/F Tai Yau Building 181 Johnston Road Wanchai Hong Kong

PRINCIPAL BANKERS

The Hongkong and Shanghai Banking Corporation Limited DBS Bank (Hong Kong) Limited Hang Seng Bank Limited Standard Chartered Bank (Hong Kong) Limited

PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN CAYMAN ISLANDS

Conyers Trust Company (Cayman) Limited Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands

BRANCH SHARE REGISTRAR AND TRANSFER OFFICE IN HONG KONG

Tricor Investor Services Limited Level 54, Hopewell Centre 183 Queen's Road East Hong Kong

STOCK CODE

The Stock Exchange of Hong Kong Limited: 01473

The board (the "Board") of directors (the "Directors") of Pangaea Connectivity Technology Limited (the "Company") is pleased to present the unaudited condensed consolidated results of the Company and its subsidiaries (collectively, the "Group") for the six months ended 30 September 2021 (the "Period"). The condensed interim financial information is not audited but has been reviewed by the audit committee of the Company (the "Audit Committee").

Market Review

The People's Republic of China (the "PRC") continued the installation of 5G base stations and network infrastructure during the financial year ended 31 March 2021. However, due to the slowdown in economic recovery during the Period, the PRC has taken a more prudent strategy on 5G deployment. In addition, the severe shortage in semiconductor ICs supply caused some customers to postpone the delivery schedule of certain products, which led to a year-on-year decrease in turnover.

Fortunately, after several months of adapting to the new normal, the market supply for infrastructure products has become increasingly stable since September 2021, with sales recording an increase since then. On the other hand, 5G infrastructure demand in the PRC is also expected to rebound, as the 14th 5-Year Plan for National Economic and Social Development and the Long-Range Objectives Through the Year 2035 provides further impetus in the coming years.

Coupled with the rising demand for the Group's other telecom and datacom connectivity products, especially in the field of high-speed network, storage capacity, and IoT, the Group has laid a solid foundation for growth in the near term.

Business Review

The Company recorded a drop in revenue of approximately 29.1% for the Period as compared to the corresponding period in 2020, which was mainly due to the worldwide severe shortages in semiconductor ICs supply.

Despite the unfavourable market development during the Period, the Group continued to expand its geographical reach in order to boost market penetration. Regarding the Greater China region, the Group has established new offices in Chengdu and Suzhou, while setting up a new office in Taiwan, in order to capture the growing market opportunities. Riding on the 5G development in the Asia Pacific region, the Group is also in the process of establishing representative offices in Malaysia, Singapore and Vietnam. As for the European market, the Group is also looking to set up a sales network in the United Kingdom, which will be used as the pivot of the Group's presence in Europe, where 5G development is now underway.

In terms of design and technical capabilities enhancement, the Group has employed 2 additional technical staff at its Shenzhen wireless and commercial laser application laboratory during the Period, as an attempt to further strengthen its product development capability. As of 30 September 2021, the Group possessed a strong and experienced inhouse design and technical team comprising 34 engineers.

Prospects

Heading into the second half of the financial year, the new wave of COVID-19 pandemic continued to bring serious challenges to global raw material supplies and operations, with the occasional spikes in cases in certain Southeast Asian countries creating significant disruptions to major suppliers in the area. However, taking references from the growing experience among countries, as well as China's excellent early success in combating COVID-19, it is expected that market supply and demand will gradually return to normal, and COVID-19 impact should become increasingly limited.

While it is still unclear when the global economy will be fully recovered from the pandemic, it is observed that industry players and consumers are adapting to the new normal, as the Group sees an obvious rebound in orders on hand, particularly in the area of telecom infrastructure, which should serve as a solid foundation for the Group's performance in the second half of the financial year.

To support the Group's future endeavors while maintaining agility in face of the everchanging market dynamics, the Group will continue to strengthen its technological capability and expand its sales networks, and will maintain its lean operation and cost structure by prioritizing cash flow and efficient use of capital, with the aim to deliver sustainable and long-term returns to its shareholders.

As announced on 15 November 2021, a wholly-owned subsidiary of the Company entered into an investment agreement with an analog and mixed signal IC innovator based in Shenzhen specialising in designing, developing and marketing high-end precision control products for optical communication, industrial control, new energy, medical instruments and artificial intelligence of things ("AIoT") with design presence in India, the United States of America and the PRC, and customer base worldwide, pursuant to which the Group has agreed to subscribe for approximately 2.4% of the enlarged share capital of the target company for a cash consideration of RMB8 million.

The Board considers that this investment will broaden the Group's product portfolio, extend the Group's presence in the value chain and further strengthen the Group's position in the optical component market. The Group's investment in the target company will create synergy to the existing business of the Group in particular this creates an opportunity for the Group to co-develop complex devices for application in industry control, new energy (such as automotive and energy storage sectors), medical and AIoT by leveraging on the target company's expertise in high end IC design and marketing.

FINANCIAL REVIEW

Revenue

Revenue is comprised of sales of goods and rendering of services.

Revenue from sales of goods accounted for approximately 99.2% of the Group's total revenue for the Period. Revenue from rendering of services mainly represented income derived from providing administrative and support services to customers. During the Period, the Company generated a substantial portion of the revenue from customers in the PRC.

Revenue from sales of goods decreased from approximately HK\$929.2 million in the six months ended 30 September 2020 to approximately HK\$653.8 million for the Period mainly due to the postponement of delivery schedule of the major customers due to severe shortages in supply of semiconductor ICs in the market and the slowdown of 5G project in PRC.

Revenue from rendering of services increased from approximately HK\$0.4 million for the six months ended 30 September 2020 to approximately HK\$5.3 million for the Period mainly due to the increase in services provided to the customers.

Cost of sales

Cost of sales comprises (i) cost of goods which represents cost of products purchased from suppliers; and (ii) cost of service which represents staff costs associated with provision of services.

Gross profit margin

Sales of goods

Gross profit margin derived from sales of goods was approximately 11.2% for the Period, as compared to approximately 12.6% for the six months ended 30 September 2020. Such decrease was mainly due to competitive selling price offered to customers for bulk purchase orders.

Rendering of services

Gross profit margin derived from rendering of services was approximately 98.3% for the Period as compared to approximately 80.6% for the six months ended 30 September 2020. As our services were provided to customers on a project basis, the gross profit margin of this segment varied depending on the scope and nature of services provided.

Other income and gains, net

Other income and gains of approximately HK\$3.2 million (2020: approximately HK\$2.7 million) mainly represents bank interest income, write back of impairment on trade receivable and sundry income. During the Period, the funding received from the Government of the Hong Kong Special Administrative Region of the PRC ("Hong Kong") in relation to the Employment Support Scheme under the Anti-epidemic Fund decreased by approximately HK\$1.6 million, which is offset by the increase in (i) sundry income in relation to the repair and maintenance of commercial laser machine of approximately HK\$0.8 million; and (ii) write back of impairment on trade receivable of approximately HK\$1.1 million.

Selling and distribution costs

The selling and distribution costs of approximately HK\$17.7 million (2020: approximately HK\$19.4 million) mainly include marketing and sales staff salaries, transportation, freight charges, declaration and research and development expenses. The selling and distribution costs decreased by approximately HK\$1.7 million or 8.9% from the corresponding period in last year, which was mainly attributable to the decrease in revenue during the Period as mentioned above.

Administrative expenses

Administrative expenses of approximately HK\$48.9 million (2020: approximately HK\$42.2 million) primarily consist of salaries and benefits (including Directors' emoluments), insurance, operating lease and other premise fee, bank charges, entertainment and depreciation expenses. The administrative expenses increased by approximately HK\$6.6 million or 15.7% for the Period, which is mainly due to (i) the share based payment expenses of approximately HK\$11.7 million incurred as a result of the share options granted under the shares option scheme of the Company as disclosed in the Company's announcement dated 20 April 2021; (ii) the increase in legal and professional fee of HK\$1.5 million mainly for the increase in compliance cost and investor relation expenses after the listing (the "Listing") of the issued shares of the Company on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") on 19 February 2021 (the "Listing Date") and consulting fee incurred for business development; which is partly offset by (a) the decrease in salaries and staff benefits in aggregate of approximately HK\$2.5 million resulting from less bonus payment during the Period; and (b) the decrease in listing expenses of approximately HK\$4.9 million.

Finance costs

The Group's finance costs of approximately HK\$5.5 million (2020: approximately HK\$8.6 million) mainly represented interest expenses on its bank borrowings during the Period. The Group incurred interest on bank borrowings of approximately HK\$5.3 million for the Period as compared to approximately HK\$8.5 million for the corresponding period in last year. The decrease in interest on bank borrowings was mainly due to the decrease in utilisation of borrowing facilities during the Period.

Taxation

Taxation of the Group for the Period mainly comprised current income tax expenses of approximately HK\$3.0 million (2020: HK\$9.9 million) and deferred tax credited to statement of profit or loss of approximately HK\$nil (2020: 0.2 million) recognized for the provision for inventories and impairment loss of trade receivable.

Net profit for the Period

Net profit for the Period amounted to approximately HK\$1.8 million, representing a decrease of approximately 95.4% as compared to approximately HK\$39.5 million for the six months ended 30 September 2020. The decrease in profit was principally attributable to the net effect of the factors mentioned above, including (a) decrease in revenue; (b) decrease in gross profit margin as a result of bulk purchase from customers; (c) increase in other income and gains, net; (d) decrease in selling and distribution costs; (e) increase in administrative expenses; (f) decrease in finance costs; and (g) decrease in taxation.

LIQUIDITY AND FINANCIAL RESOURCES

During the Period, the Group met its liquidity requirements principally through a combination of internal resources and bank borrowings. The Group's cash resources as at 30 September 2021 were approximately HK\$178.1 million (31 March 2021: HK\$146.8 million). They were mainly denominated in Hong Kong dollar and Renminbi. As at 30 September 2021, the Group's total outstanding bank borrowings amounted to approximately HK\$438.9 million (31 March 2021: HK\$252.5 million) which comprised mainly bank factoring loans, import loans, trust receipts loans and revolving loans. The Group's bank borrowings which were unrestricted with a clause of repayment on demand are classified as current liability. The bank borrowings were denominated in Hong Kong dollar and United States ("US") dollar and were subject to interest at floating commercial lending rates.

The Group's gearing ratio (defined as the total interest-bearing borrowings net of cash and cash equivalents divided by total equity and multiplied by 100%) and debt-to-assets ratio (defined as the total borrowings net of cash and cash equivalents divided by total assets and multiplied by 100%) increased from approximately 39.4% and 14.3% respectively as at 31 March 2021 to approximately 97.0% and 30.3% respectively as at 30 September 2021, mainly due to increase in bank borrowing resulting from increase in inventory, pledged bank deposit and decrease in trade payables of approximately HK\$80.7 million, HK\$21.7 million and HK\$58.9 million, respectively.

The Group had no significant contingent liabilities as at the end of the Period. The Group possesses sufficient cash and available banking facilities to meet its commitments and working capital requirements.

TREASURY POLICIES AND FOREIGN CURRENCY EXPOSURE

The Group's financial statements are presented in Hong Kong dollars. The Group carried out its business transactions mainly in Hong Kong dollar, US dollar and Renminbi. As the Hong Kong dollar remains pegged to the US dollar, there was no material exchange risk in this respect. As the portion of Renminbi revenue is insignificant, there was no material exchange risk in this respect. The Group currently does not have any interest rate hedging policy. However, the management monitors the Group's exposure to interest rate risk on an ongoing basis and will consider hedging interest rate risk should the need arise. Credit risk was hedged mainly through credit policy and factored to external financial institutions.

CONTINGENT LIABILITIES

As at 30 September 2021, the Group did not have any material contingent liabilities (31 March 2021: Nil).

CHARGES ON ASSETS

As at 30 September 2021, certain bank borrowings of the Group were secured by:

  • (i) the pledge of the Group's bank deposits amounting to HK\$77,599,000 (31 March 2021: HK\$55,901,000);
  • (ii) mortgages over the Group's owned buildings and right-of-use land situated in Hong Kong, which had an aggregate carrying value of HK\$Nil (31 March 2021: HK\$25,935,000);
  • (iii) the pledge of investments in life insurance policies of Mr. Fung Yui Kong, amounting to HK\$16,185,000 (31 March 2021: HK\$15,970,000); and
  • (iv) trade and bills receivable of HK\$68,539,000 (31 March 2021: HK\$136,919,000)

SIGNIFICANT INVESTMENT

During the Period, the Group did not acquire or hold any significant investment with a value of 5% or more of the Group's total assets.

MATERIAL ACQUISITIONS AND DISPOSALS OF SUBSIDIARIES, ASSOCIATES AND JOINT VENTURES

The Group did not have any material acquisitions and disposals of subsidiaries, associates and joint ventures during the Period.

EMPLOYEES AND REMUNERATION POLICY

As at 30 September 2021, the Group had 121 employees (30 September 2020: 126 employees). Salaries of employees are maintained at a competitive level and are reviewed annually, with close reference to individual performance, working experience, qualification and the current relevant industry practices. Apart from basic salary and statutory provident fund scheme, discretionary bonus and share options may be granted to selected staff by reference to the Group's as well as the individual's performances. Other forms of benefits such as on-the-job and external training to staff are also provided. The Group has not experienced any material dispute with its employees or disruption to its operations due to employee dispute and has not experienced any difficulties in the recruitment and retention of experienced staff or skilled personnel. The Group maintains a good relationship with its employees.

EVENTS AFTER THE END OF THE PERIOD

No matters or circumstances have occurred subsequent to the end of the Period which has significantly affected, or may significantly affect, the operations of the Group, the results of those operations or the state-of-affairs of the Group.

USE OF NET PROCEEDS FROM LISTING

The net proceeds received by the Company from the Listing in the amount of approximately HK\$88.1 million after deducting underwriting commissions and all related expenses have been and will be used in the manner consistent with that mentioned in the section headed "Future Plans and Use of Proceeds" in the prospectus of the Company dated 30 January 2021 (the "Prospectus").

The net proceeds received were applied by the Group from the Listing Date up to 30 September 2021 as follows:

Use of proceeds Application of
net proceeds
as stated
in the
Prospectus
HK\$'million
Utilised
amount up to
30 September
2021
HK\$'million
Unused
net proceeds
HK\$'million
Unused
net proceeds
%
Strengthening design and
technical capabilities
Broadening customer base
57.8 0.1 57.7 99.8%
by expanding the geographic
reach of sales and technical
support coverage
14.4 1.9 12.5 86.8%
Strengthening back office
operational supports by
enhancing information
technology management
system and recruiting IT staff 7.2 0.4 6.8 94.4%
General working capital 8.7 8.7 0 0%
88.1 11.1 77.0 87.4%

As at 30 September 2021, the amount of unused net proceeds amounted to approximately HK\$77.0 million. The remaining unused net proceeds are expected to be utilised on or before 31 March 2024 according to the above proposed uses of proceeds.

DISCLOSURE OF INTEREST

(a) Interests of Directors

As at 30 September 2021, the interests and short positions of the Directors and the chief executive of the Company in the shares, underlying shares and debentures of the Company or its associated corporation (within the meaning of Part XV of the SFO) as recorded in the register required to be kept by the Company under section 352 of the Securities and Futures Ordinance (the "SFO"), or as otherwise notified to the Company and the Stock Exchange pursuant to the Model Code for Securities Transactions by Directors of Listed Issuers contained in Appendix 10 to the Rules (the "Listing Rules") Governing the Listing of Securities on the Stock Exchange (the "Model Code"), were as follows:

Name of Directors Nature of interest Interest in
shares/
underlying
shares
Total
shares/
underlying
shares
Approximate
percentage of
issued
share capital
Mr. Fung Yui Kong Interest in controlled 750,000,000 750,000,000 75.00
corporation (Note 1)
Ms. Leung Kwan Beneficial owner 10,000,000 10,000,000 1.00
Sin Rita (Note 2) (Note 2)
Dr. Wong Wai Kong Beneficial owner 6,500,000 6,500,000 0.65
(Note 2) (Note 2)
Mr. Kam Eddie Beneficial owner 300,000 300,000 0.03
Shing Cheuk (Note 2) (Note 2)
Mr. Chan Hiu Beneficial owner 300,000 300,000 0.03
Fung Nicholas (Note 2) (Note 2)
Mr. Ling Kwok Beneficial owner 300,000 300,000 0.03
Fai Joseph (Note 2) (Note 2)
Mr. Sze Wing Chun Beneficial owner 300,000 300,000 0.03
(Note 2) (Note 2)

(i) Long position in the shares and underlying shares of the Company

Notes:

    1. These shares are held by Generous Horizon Limited (formerly named Generous Team Limited), a company incorporated in the British Virgin Islands with limited liability and the entire issued share capital of which is legally and beneficially owned by Mr. Fung Yui Kong.
    1. These are underlying shares which represent the share options granted by the Company on 20 April 2021 under the share option scheme of the Company adopted on 25 January 2021, exercisable according to the schedule set out in the paragraph headed "Share Option Scheme" in this report.
Name of Director Name of associated
corporation
Capacity Number of
share(s) held in
the associated
corporation
Percentage of
issued share
capital
Mr. Fung Yui Kong Generous Horizon
Limited
Beneficial owner 1 100

(ii) Long position in the shares of associated corporation(s) of the Company

Save as disclosed above, as at 30 September 2021, none of the Directors nor the chief executive of the Company had or was deemed to have any interests and short positions in the shares, underlying shares and debentures of the Company or any of its associated corporation (within the meaning of Part XV of the SFO) as recorded in the register required to be kept by the Company under section 352 of the SFO, or as otherwise notified to the Company and the Stock Exchange pursuant to the Model Code.

(b) Interests of substantial shareholders

As at 30 September 2021, so far as is known to the Directors, the following persons (not being Directors or chief executive of the Company) had, or were deemed to have, interests or short positions in the shares and underlying shares of the Company which were required to be disclosed to the Company and the Stock Exchange under the provisions of Divisions 2 and 3 of Part XV of the SFO, or which were recorded in the register required to be kept by the Company under section 336 of the SFO:

Name of Shareholders Nature of interest No. of shares
held
Percentage of
issued
share capital
Generous Horizon Limited Beneficial owner 750,000,000 (L)
(Note 1)
75
Ms. Lam Esther W. Interest of spouse 750,000,000 (L)
(Note 2)
75

(L) denotes long position

Notes:

    1. Generous Horizon Limited (formerly named Generous Team Limited) is a company incorporated in the British Virgin Islands with limited liability, the entire issued share capital of which is legally and beneficially owned by Mr. Fung Yui Kong.
    1. Ms. Lam Esther W. is the spouse of Mr. Fung Yui Kong. As such, she is deemed to be interested in the shares in which Mr. Fung Yui Kong is interested under Part XV of the SFO.

Save as disclosed above, as at 30 September 2021, the Directors were not aware of any other person (other than the Directors or the chief executive of the Company) who had, or was deemed to have, interest or short position in the shares and underlying shares of the Company which were required to be disclosed to the Company and the Stock Exchange under the provisions of Divisions 2 and 3 of Part XV of the SFO, or which were recorded in the register required to be kept by the Company under section 336 of the SFO.

SHARE OPTION SCHEME

The Company operates a share option scheme (the "Share Option Scheme") for the purpose of providing incentives and rewards to eligible participants for their contribution to the Group and/or to enable the Group to recruit and retain high-calibre employees and attract human resources that are valuable to the Group or any entity in which the Group holds an equity interest (the "Invested Entity"). Eligible participants of the Share Option Scheme include the Directors, including executive, non-executive and independent nonexecutive Directors, other employees of the Group, suppliers of goods or services to the Group, customers of the Group, any consultant, adviser, manager, officer or entity that provides research, development or other technological support to the Group or any Invested Entity, any person who, in the sole discretion of the Board, has contributed or may contribute to the Group or any Invested Entity eligible for options under the Share Option Scheme (the "Eligible Participant"). The Share Option Scheme became effective on 25 January 2021 and, unless otherwise cancelled or amended, will remain in force for 10 years from that date.

The total number of shares which may be allotted and issued upon exercise of all options to be granted under the Share Option Scheme and any other share option schemes of the Company must not exceed 100,000,000 shares, being 10% of the total number of shares in issue unless the Company obtains the approval of the shareholders in general meeting for renewing the 10% limit (the "Scheme Mandate Limit") under the Share Option Scheme provided that options lapsed in accordance with the terms of the Share Option Scheme or any other share option schemes of the Company will not be counted for the purpose of calculating whether the Scheme Mandate Limit has been exceeded. The maximum number of shares which may be issued upon the exercise of all outstanding options granted and yet to be exercised under the Share Option Scheme and any other share option schemes of the Company shall not, in aggregate, exceed 30% of the total number of shares in issue from time to time.

No option shall be granted to any Eligible Participant if any further grant of options would result in the shares issued and to be issued upon exercise of all options granted and to be granted to such person (including both exercised and outstanding options) in the 12-month period up to and including the date of such further grant exceeding 1% of the total number of shares in issue.

Share options granted to a director, chief executive or substantial shareholder of the Company, or to any of their associates, are subject to approval in advance by the independent non-executive Directors. In addition, any share options granted to a substantial shareholder or an independent non-executive director of the Company, or to any of their associates, in excess of 0.1% of the shares of the Company in issue at any time or with an aggregate value (based on the price of the Company's shares at the date of grant) in excess of HK\$5 million, within any 12-month period, are subject to shareholders' approval in advance in a general meeting.

An offer of grant of an option may be accepted by an Eligible Participant within 21 days from the date upon which it is made or within such other period of time as may be determined by the Board pursuant to the Listing Rules, by which the Eligible Participant must accept the offer or be deemed to have declined it, provided that such date shall not be more than ten (10) years after the date of adoption of the Share Option Scheme. A consideration of HK\$1.00 is payable on acceptance of the offer of grant of an option.

The exercise price of share options is determinable by the Directors, but may not be less than the higher of (i) the Stock Exchange closing price of the Company's shares on the date of offer of the share options; and (ii) the average Stock Exchange closing price of the Company's shares for the five trading days immediately preceding the date of offer.

Share options do not confer rights on the holders to dividends or to vote at shareholders' meetings.

On 20 April 2021 (the "Date of Grant"), the Company granted share options to the Eligible Participants to subscribe for a total of 78,464,000 ordinary shares of HK\$0.01 each at the exercise price of HK\$0.60 per share. Among the 78,464,000 share options granted, a total of 17,700,000 share options were granted to certain Directors in respect of their services to the Group in the forthcoming years. 38,464,000 options shall be exercisable as to 30%, 30% and 40% from the first anniversary of the Date of Grant, the second anniversary of the Date of Grant and the third anniversary of the Date of Grant, respectively, until the expiry of the validity period of the options. 40,000,000 options shall be exercisable as to 25%, 25%, 25% and 25% from the date falling 6 months, 12 months, 18 months and 24 months from the Date of Grant, respectively, until the expiry of the validity period of the options.

As at 30 September 2021, the following share options granted under the Share Option Scheme were outstanding:

Name or
category of
participant
As at
1 April
2021
Granted
during the
Period
Exercised
during the
Period
Lapsed/
cancelled
during the
Period
As at
30 September
2021
Date of
grant
(Note 2)
No. of
option for
exercise
period I
(Note 3)
No. of
option for
exercise
period II
(Note 4)
Exercise
price
per share
HK\$
(Note 5)
Closing price
per share
as at
the Date of
Grant
HK\$
(Note 6)
Closing price
per share
immediately
before
the Date of
Grant
HK\$
Directors
Ms. Leung Kwan Executive Director 10,000,000 10,000,000 20 April 2021 5,000,000 5,000,000 0.6 0.59 0.59
Sin Rita
Dr. Wong
Executive Director 6,500,000 6,500,000 20 April 2021 1,500,000 5,000,000 0.6 0.59 0.59
Wai Kong
Mr. Kam Eddie
Shing Cheuk
Non-executive Director 300,000 300,000 20 April 2021 300,000 0.6 0.59 0.59
Mr. Chan Hiu
Fung Nicholas
Independent
non-executive
300,000 300,000 20 April 2021 300,000 0.6 0.59 0.59
Mr. Ling Kwok
Fai Joseph
Director
Independent
non-executive
300,000 300,000 20 April 2021 300,000 0.6 0.59 0.59
Mr. Sze Wing
Chun
Director
Independent
non-executive
Director
300,000 300,000 20 April 2021 300,000 0.6 0.59 0.59
17,700,000 17,700,000 7,700,000 10,000,000
Employees in
aggregate
60,764,000 60,764,000 30,764,000 30,000,000 0.6 0.59 0.59
Total number of
share options
78,464,000 78,464,000 38,464,000 40,000,000

Notes:

    1. The relevant share options were granted under the Share Option Scheme of the Company adopted on 25 January 2021.
    1. All options are exercisable during the exercise periods specified in below notes 3 and 4.
    1. Exercise Period I: 38,464,000 options shall be exercisable as to 30%, 30% and 40% from the first anniversary (i.e. 20 April 2022) of the Date of Grant, the second anniversary (i.e. 20 April 2023) of the Date of Grant and the third anniversary (i.e. 20 April 2024) of the Date of Grant respectively until the expiry of the validity period (i.e. 20 April 2031) of the options.
    1. Exercise Period II: 40,000,000 options shall be exercisable as to 25%, 25%, 25% and 25% from the date falling 6 months (i.e. 20 October 2021), 12 months (i.e. 20 April 2022), 18 months (i.e. 20 October 2022) and 24 months (i.e. 20 April 2023) from the Date of Grant respectively until the expiry of the validity period (i.e. 20 April 2031) of the options.
    1. The exercise price of the share options is subject to adjustments.
    1. The price of the Company's shares at the Date of Grant is the closing price of the shares as stated in the Stock Exchange's daily quotations sheet on the Date of Grant.
    1. No information on the exercise price and the weighted average closing price of the securities immediately before the exercise date has been disclosed as there was no share option exercised during the Period.

PURCHASE, SALE OR REDEMPTION OF LISTED SECURITIES OF THE COMPANY

Neither the Company nor any of its subsidiaries has purchased, sold or redeemed any of the Company's listed securities during the Period.

CORPORATE GOVERNANCE

The Company is committed to maintaining good corporate governance practices. The Company believes that good corporate governance provides a framework that is essential for effective management, a healthy corporate culture, successful business growth and enhancement of shareholders value. Except for the deviation from code provision A.2.1 of the Corporate Governance Code (the "CG Code") as set out in Appendix 14 to the Listing Rules, which provides that the roles of chairman and chief executive should be separate and should not be performed by the same individual, the Company has complied with all the code provisions set out in the CG Code.

Mr. Fung Yui Kong ("Mr. Fung") is the chairman of the Board and the chief executive of the Company. In view of Mr. Fung being the founder of the Group and that he has considerable experience in operating and managing the Company since 1990, the Board believes that it is in the best interest of the Group to have Mr. Fung taking up both the role of chairman and chief executive for effective management and business development. The Board considers that the balance of power between the Board and the management can still be maintained under the current structure. Therefore, the Directors consider that the deviation from the code provision A.2.1 of the CG Code is appropriate in such circumstance.

Save as disclosed, the Company has applied the principles and complied with the CG Code throughout the Period.

AUDIT COMMITTEE

The Audit Committee was established on 25 January 2021 with specific terms of reference setting out the committee's authority and duties. The Audit Committee comprises one non-executive Director namely Mr. Kam Eddie Shing Cheuk and two independent nonexecutive Directors namely Mr. Sze Wing Chun (Chairman), who possesses the appropriate professional qualifications or accounting or related financial management expertise, and Mr. Ling Kwok Fai Joseph. None of the members of the Audit Committee is a former partner of the Company's existing external auditors. The Audit Committee has discussed with management the accounting policies adopted by the Group and reviewed the unaudited condensed interim financial statements of the Group for the Period before recommending them to the Board for approval.

RISK MANAGEMENT COMMITTEE

The risk management committee of the Company (the "Risk Management Committee") was established on 25 January 2021 with specific terms of reference setting out the committee's authority and duties. The Risk Management Committee comprises three executive Directors namely Mr. Fung Yui Kong (Chairman), Ms. Leung Kwan Sin Rita and Dr. Wong Wai Kong. The main duties of the Risk Management Committee include, among other matters, to monitor the Company's exposure to sanctions law risks and its implementation of the related internal control procedures, with particular emphasis on the Company's risk management policies and standards and supervise and monitor the Company's exposure to sanctions law risks. During the Period, there were no irregular findings in relation to any transactions of the Group made by the Risk Management Committee which were required to be reported to the independent non-executive Directors.

MODEL CODE FOR SECURITIES TRANSACTIONS BY DIRECTORS

The Company has adopted the Model Code as its own code of conduct governing securities transactions by the Directors. All Directors, after specific enquiries by the Company, had confirmed to the Company their compliance with the required standards set out in the Model Code during the Period.

INTERIM DIVIDEND

The Board resolved not to declare any interim dividend for the Period.

APPROVAL OF THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

The unaudited condensed interim financial statements were approved and authorised for issue by the Board on 18 November 2021.

CONDENSED CONSOLIDATED STATEMENT OF PROFIT AND LOSS

Unaudited
For the six months ended
30 September
Notes 2021
HK\$'000
2020
HK\$'000
REVENUE 4 659,121 929,665
Cost of sales (585,519) (812,540)
Gross profit 73,602 117,125
Other income and gains, net
Selling and distribution costs
4 3,221
(17,688)
2,675
(19,420)
Administrative expenses
Finance costs
5 (48,851)
(5,460)
(42,208)
(8,638)
PROFIT BEFORE TAX 6 4,824 49,534
Income tax expense 7 (2,991) (10,010)
PROFIT FOR THE PERIOD ATTRIBUTABLE
TO OWNERS OF THE PARENT
1,833 39,524
EARNINGS PER SHARE ATTRIBUTABLE
TO ORDINARY EQUITY HOLDERS OF
THE PARENT
Basic (HK cents) 9 0.18 5.27
Diluted (HK cents) 9 0.18 5.27

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

Unaudited
For the six months ended
30 September
2021
HK\$'000
2020
HK\$'000
Profit for the period 1,833 39,524
OTHER COMPREHENSIVE INCOME:
Other comprehensive income that may
be reclassified to profit or loss in subsequent periods:
Exchange differences on translation of a
foreign operation
31 703
OTHER COMPREHENSIVE INCOME FOR THE PERIOD 31 703
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
ATTRIBUTABLE TO OWNERS OF THE PARENT
1,864 40,227

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 September 2021

Notes Unaudited
30 September
2021
HK\$'000
Audited
31 March
2021
HK\$'000
NON-CURRENT ASSETS
Property, plant and equipment
10 45,399 43,003
Financial assets at fair value through
profit or loss 11 23,985 15,970
Deferred tax assets 418 416
Total non-current assets 69,802 59,389
CURRENT ASSETS
Inventories
316,549 235,896
Trade and bills receivables 12 190,368 183,058
Prepayments, deposits, other receivables
and other assets 28,074 54,148
Pledged bank deposits 77,599 55,901
Cash and cash equivalents 178,146 146,809
Total current assets 790,736 675,812
CURRENT LIABILITIES
Trade payables 13 119,701 178,607
Other payables, accruals and contract liabilities 16,552 19,870
Interest-bearing bank borrowings 82,834 39,777
Trust receipt loans 356,038 212,725
Lease liabilities 5,167 4,344
Tax payable 7,047 7,895
Total current liabilities 587,339 463,218
NET CURRENT ASSETS 203,397 212,594
TOTAL ASSETS LESS CURRENT LIABILITIES 273,199 271,983

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 September 2021

Unaudited
30 September
2021
HK\$'000
Audited
31 March
2021
HK\$'000
NON-CURRENT LIABILITIES
Lease liabilities
4,288 3,598
Deferred tax liabilities
Total non-current liabilities
190
4,478
190
3,788
Net assets 268,721 268,195
EQUITY
Equity attributable to owners of the parent
Share capital 10,000 10,000
Reserves 258,721 258,195
Total equity 268,721 268,195

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Attributable to owners of the parent
For the six months ended
30 September 2021 (Unaudited)
Share
capital
HK\$'000
Share
premium
HK\$'000
Reserve
under share
option
scheme
HK\$'000
Contributed
surplus
HK\$'000
Exchange
fluctuation
reserve
HK\$'000
Retained
profits
HK\$'000
Total
HK\$'000
At 1 April 2021 (audited)
Profit for the period
Other comprehensive expense
for the period:
Exchange differences on translation
of a foreign operation
10,000

105,146



625

72

31
152,352
1,833
268,195
1,833
31
Total comprehensive income/(expense)
for the period 31 31
Dividends declared (note 8)
Share based payment expenses



11,662


(13,000)
(13,000)
11,662
At 30 September 2021 10,000 105,146 11,662 625 103 141,185 268,721
Attributable to owners of the parent
Shares held
For the six months ended Share Share under share
award
Contributed Exchange
fluctuation
Retained
30 September 2020 (Unaudited) capital premium scheme surplus reserve profits Total
HK\$'000 HK\$'000 HK\$'000 HK\$'000 HK\$'000 HK\$'000 HK\$'000
At 1 April 2020 (audited) 626 (1,706) 122,623 121,543
Profit for the period 39,523 39,523
Other comprehensive expense
for the period:
Exchange differences on translation
of a foreign operation 703 703
Total comprehensive income/(expense)
for the period 703 161,769
Dividends declared (note 8) (20,400) (20,400)
At 30 September 2021 626 (1,003) 141,746 141,369

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

Unaudited
For the six months ended
30 September
Notes 2021
HK\$'000
2020
HK\$'000
CASH FLOWS FROM OPERATING ACTIVITIES
Profit before tax 4,824 49,534
Adjustments for:
Interest income
4 (117) (249)
Finance costs 5 5,460 8,638
Impairment/(reversal of impairment)
of trade receivables 6 (1,053) 162
Write-down of inventories to
net realisable value 6 9,947 17,033
Gain on disposal of owned items of
property, plant and equipment 6 (13)
Share based payment expenses for
share option
6 11,662
Depreciation 6 4,701 4,177
Fair value gain on financial assets
at fair value through profit or loss 6 (215) (171)
35,196 79,124
Increase in inventories (90,600) (22,194)
Increase in trade and bills receivables (6,257) (35,467)
Decrease/(increase) in prepayments,
deposits and other receivables
26,074 (46,499)
Increase/(decrease) in trade payables (58,906) 18,313
Increase/(decrease) in other payables,
accruals and contract liabilities (3,318) 7,117
Exchange realignment 3 225

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

Unaudited For the six months ended
30 September
2021 2020
Notes HK\$'000 HK\$'000
Cash (used in)/generated from operations (97,808) 619
Hong Kong profits tax paid (2,074) (1,597)
Overseas tax paid (1,767) (903)
Net cash flows used in operating activities (101,649) (1,881)
CASH FLOWS FROM INVESTING ACTIVITIES
Interest received 117 249
Purchase of owned items of property,
plant and equipment (2,842) (906)
Proceeds from disposals of owned items of
property plant and equipment 57
Purchase of financial assets at fair value
through profit or loss
(7,800)
Increase in pledged bank deposits (21,698) (11,907)
Net cash flows used in investing activities (32,166) (12,564)
CASH FLOWS FROM FINANCING ACTIVITIES
Increase in trust receipt loans, net 143,313 58,475
New other bank loans 331,372 793,961
Repayment of other bank loans (288,315) (782,225)
Interest paid (5,460) (8,638)
Dividend paid (13,000) (20,400)
Repayment of the principal
portion of lease liabilities (2,798) (2,571)
Net cash flows from financing activities 165,112 38,602

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

Unaudited
For the six months ended
30 September
Notes 2021
HK\$'000
2020
HK\$'000
NET INCREASE IN CASH
AND CASH EQUIVALENTS 31,297 24,157
Cash and cash equivalents at beginning of year 146,809 33,137
Effect of foreign exchange rate changes, net 40 39
CASH AND CASH EQUIVALENTS
AT END OF YEAR
178,146 57,333
ANALYSIS OF BALANCES OF CASH
AND CASH EQUIVALENTS
Cash and cash equivalents as stated in the
condensed consolidated statement of
financial position and the condensed
consolidated statements of cash flows 178,146 57,333

1 BASIS OF PRESENTATION

The condensed consolidated interim financial statements are prepared in accordance with Hong Kong Accounting Standard ("HKAS") 34 Interim Financial Reporting issued by the Hong Kong Institute of Certified Public Accountants (the "HKICPA") and the disclosure requirements of Appendix 16 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules"). Save for the adoption of revised Hong Kong Financial Reporting Standards ("HKFRSs") during the period as set out in note 2 below, the accounting policies and basis of preparation adopted in the preparation of the condensed consolidated interim financial statements are the same as those used in the preparation of the annual financial statements for the year ended 31 March 2021.

2 IMPACT OF REVISED HONG KONG FINANCIAL REPORTING STANDARDS

The Group has adopted the following revised HKFRSs for the first time for the current period's condensed consolidated interim financial statements.

Amendments to HKFRS 9, HKAS 39, HKFRS 7, HKFRS 4 and HKFRS 16

Interest Rate Benchmark Reform — Phase 2

2 IMPACT OF REVISED HONG KONG FINANCIAL REPORTING STANDARDS (Continued)

The nature and impact of the revised HKFRSs are described below:

Amendments to HKFRS 9, HKAS 39, HKFRS 7, HKFRS 4 and HKFRS 16 address issues not dealt with in the previous amendments which affect financial reporting when an existing interest rate benchmark is replaced with an alternative risk-free rate ("RFR"). The phase 2 amendments provide a practical expedient to allow the effective interest rate to be updated without adjusting the carrying amount of financial assets and liabilities when accounting for changes in the basis for determining the contractual cash flows of financial assets and liabilities, if the change is a direct consequence of the interest rate benchmark reform and the new basis for determining the contractual cash flows is economically equivalent to the previous basis immediately preceding the change. In addition, the amendments permit changes required by the interest rate benchmark reform to be made to hedge designations and hedge documentation without the hedging relationship being discontinued. Any gains or losses that could arise on transition are dealt with through the normal requirements of HKFRS 9 to measure and recognise hedge ineffectiveness. The amendments also provide a temporary relief to entities from having to meet the separately identifiable requirement when an RFR is designated as a risk component. The relief allows an entity, upon designation of the hedge, to assume that the separately identifiable requirement is met, provided the entity reasonably expects the RFR risk component to become separately identifiable within the next 24 months. Furthermore, the amendments require an entity to disclose additional information to enable users of financial statements to understand the effect of interest rate benchmark reform on an entity's financial instruments and risk management strategy. The amendments did not have any impact on the financial position and performance of the Group.

3 OPERATING SEGMENT INFORMATION

The Group is principally engaged in the import and export of connectivity products which are used in telecom and datacom connectivity industry.

Almost all of the Group's products are of a similar nature and subject to similar risks and returns.

Accordingly, the Group's operating activities are attributable to a single reportable operating segments.

Geographical information

(a) Revenue from external customers

Unaudited
For the six months ended
30 September
2021 2020
HK\$'000 HK\$'000
Hong Kong 110,855 80,541
Mainland China 447,337 804,781
Other countries/regions 100,929 44,343
659,121 929,665

The revenue information above is based on the locations of the customers.

3 OPERATING SEGMENT INFORMATION (Continued)

Geographical information (Continued)

(b) Non-current assets

Unaudited
For the six months ended
30 September
2021
HK\$'000
2020
HK\$'000
Hong Kong
Mainland China
33,093
12,306
37,791
5,212
45,399 43,003

The non-current asset information above is based on the locations of the assets and excludes financial instruments and deferred tax assets.

3 OPERATING SEGMENT INFORMATION (Continued)

Information about major customers

Revenue derived from sales to individual customers which contributed over 10% of the total revenue of the Group during the Period is as follows:

Unaudited
For the six months ended
30 September
2021 2020
HK\$'000 HK\$'000
Customer A 170,886 338,252
Customer B * 104,596
170,886 442,848

The above amounts include sales to a group of entities which are known to be under common control with these customers.

* Sales to Customer B is less than 10% of the total revenue of the Group for the six months ended 30 September 2021.

4 REVENUE AND OTHER INCOME AND GAINS, NET

An analysis of revenue is as follows:

Unaudited
For the six months ended
30 September
2021
HK\$'000
2020
HK\$'000
Revenue from contracts with customers
Sale of goods 653,821 929,240
Rendering of services 5,300 425
659,121 929,665
Revenue from contracts with customers
Disaggregated revenue information
Timing of revenue recognition
At a point in time 653,821 929,240
Over time 5,300 425
659,121 929,665

4 REVENUE AND OTHER INCOME AND GAINS, NET (Continued)

An analysis of other income and gains, net is as follows:

Unaudited
For the six months ended
30 September
2021 2020
HK\$'000 HK\$'000
Bank interest income 117 249
Exchange differences, net (476) (765)
Fair value gain on financial assets
at fair value through profit or loss 215 46
Reversal of impairment of trade receivables 1,053
Government subsidies* 1,640
Gain on disposal of owned items of
property, plant and equipment 13
Sundry income, net 2,299 1,505
3,221 2,675

* Government subsidies were granted by the Government of the Hong Kong Special Administrative Region under the Anti-Epidemic Fund. There were no unfulfilled conditions and other contingencies attached to the receipts of those subsidies.

5 FINANCE COSTS

An analysis of finance costs is as follows:

Unaudited
For the six months ended
30 September
2021 2020
HK\$'000 HK\$'000
Interest on bank borrowings 5,294 8,501
Interest on lease liabilities 166 137
Total finance costs 5,460 8,638

6 PROFIT BEFORE TAX

The Group's profit before tax is arrived at after charging/(crediting):

Unaudited
For the six months ended
30 September
2021
HK\$'000
2020
HK\$'000
Cost of inventories sold 585,431 812,458
Cost of services provided
Depreciation
88
4,701
82
4,177
Research and development costs# 5,330 5,430
Auditors' remuneration
— annual audit 500 400
— act as reporting accountant* 1,210
Impairment/(reversal of impairment)
of trade receivables^ (1,053) 162
Write-down of inventories to net realisable value^^
Gain on disposal of owned items of property,
9,947 17,033
plant and equipment 13
Listing expenses 4,876
Staff costs (including directors' remuneration):
Wages and salaries 24,539 26,908
Share based payment expenses
for share option^
Pension scheme contributions
11,662
3,078

1,539
39,279 28,447
Lease payments not included in the
measurement of leases liabilities 215 196
Foreign exchange differences, net 476 765
Fair value gain on financial assets
at fair value through profit or loss (215) (171)

6 PROFIT BEFORE TAX (Continued)

  • The research and development costs include HK\$4,159,000 (six months ended 30 September 2020: HK\$3,623,000) relating to staff costs for research and development activities, which are also included in the total amounts disclosed above for each of these types of expenses for the period.

  • * The auditor's remuneration for acting as a reporting accountants is included in the listing expenses.
  • ^ The impairment/(reversal of impairment) of trade receivables and share based payment expenses for share option are included in "Other income and gains, net" and "Administrative expenses" on the face of the condensed consolidated statement profit or loss.
  • ^^ The write-down of inventories to net realisable value is included in "Cost of sales" on the face of the condensed consolidated statement of profit or loss.

7 INCOME TAX

Hong Kong profits tax has been provided at the rate of 16.5% (2020: 16.5%) on the estimated assessable profits arising in Hong Kong during the Period, except for one subsidiary of the Group which is a qualifying entity under the two-tiered profits tax regime.

The first HK\$2,000,000 (2020: HK\$2,000,000) of assessable profit of this subsidiary are taxed at 8.25% (2020: 8.25%) and the remaining assessable profits are taxed at 16.5% (2020: 16.5%). The Company's subsidiary operating in Mainland China is subject to the prevailing PRC income tax rate of 25%.

Unaudited
For the six months ended
30 September
2021
2020
HK\$'000
HK\$'000
Current — Hong Kong
Charge for the period 2,700 8,800
Underprovision in prior years
Current — Mainland China
172
Charge for the period 291 332
Underprovision in prior years 552
Deferred tax 154
Total tax charge for the period 2,991 10,010

8 DIVIDENDS

No interim dividend was proposed during the current period. The dividends paid during the periods were as follows:

Unaudited
30 September
For the six months ended
2021
HK\$'000
2020
HK\$'000
Dividends paid during the period
— final at HK1.3 cents per ordinary share
(2020: N/A)
13,000 20,400

For the period ended 30 September 2020, the dividends were declared by the subsidiaries of the Company to their then shareholder. Investors who became the shareholders of the Company after the listing on the Stock Exchange on 19 February 2021 were not entitled to these dividends.

9 EARNINGS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE PARENT

a. Basic earnings per share

The calculation of basic earnings per share attributable to ordinary equity holders of the parent is based on the profit for the period attributable to ordinary equity holders of the parent of HK\$1,833,000 (2020: HK\$39,524,000) and the weighted average number of ordinary shares of 1,000,000,000 (2020: 750,000,000) in issue during the period, on the assumption that the capitalisation issue in connection with the listing of the Company had been completed on 1 April 2020 for calculating the basic earnings per share amount.

b. Diluted earnings per share

For the six months ended 30 September 2020, no adjustment has been made to the basic earnings per share as the Group had no potentially dilutive ordinary shares in issue during the six months ended 30 September 2020.

For the six months ended 30 September 2021, no adjustment has been made to the basic earnings per share in respect of a dilution as the impact of the share options outstanding had no dilutive effect on the earnings per share.

10 PROPERTY, PLANT AND EQUIPMENT

The changes in the net book value of property, plant and equipment for the six months ended 30 September 2021 are analysed as follows:

Owned
assets
HK\$'000
Right-of-use
assets
HK\$'000
Total
HK\$'000
At 1 April 2021 (Audited)
Additions
Depreciation
Disposals
Exchange realignment
14,203
2,842
(1,516)
(44)
47
28,800
4,312
(3,185)

(60)
43,003
7,154
(4,701)
(44)
(13)
At 30 September 2021 (Unaudited) 15,532 29,867 45,399

11 FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT AND LOSS AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS

The changes in the carrying value of financial assets at fair value through profit and loss for the six months ended 30 September 2021 are analysed as follows:

HK\$'000
At 1 April 2021 (Audited) 15,970
Additions 7,800
Change in fair value 215
At 30 September 2021 23,985

11 FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT AND LOSS AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS (Continued)

Fair value hierarchy of financial instruments

The following table illustrates the fair value measurement hierarchy of the Group's instruments:

Fair value measurement using
Quoted
prices
in active
markets
(Level 1)
HK\$'000
Significant
observable
inputs
(Level 2)
HK\$'000
Significant
unobservable
inputs
(Level 3)
HK\$'000
Total
HK\$'000
As 30 September 2021
Financial assets at fair value through
profit or loss:
Investments in life insurance policies^
Investment in convertible bond^^


16,185
7,800
16,185
7,800
Financial assets at fair value through
other comprehensive income:
Trade receivables^^^ 24,320 24,320
24,320 23,985 48,305

11 FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT AND LOSS AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS (Continued)

Fair value hierarchy of financial instruments (Continued)

Fair value measurement using
Quoted
prices
in active
markets
(Level 1)
HK\$'000
Significant
observable
inputs
(Level 2)
HK\$'000
Significant
unobservable
inputs
(Level 3)
HK\$'000
Total
HK\$'000
At 31 March 2021
Financial assets at fair value through
profit or loss:
Investments in life insurance policies^
15,970 15,970
Financial assets at fair value through
other comprehensive income:
Trade receivables^^^ 60,918 60,918
60,918 15,970 76,888

11 FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT AND LOSS AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS (Continued)

Fair value hierarchy of financial instruments (Continued)

During the six months ended 30 September 2021, there were no transfers between levels of the fair value hierarchy (six months ended 30 September 2020: nil). The Group subscribed for certain convertible bond during the Period which is disclosed in Level 3 above.

  • ^ The fair value of the investments in life insurance policies is determined by reference to the surrender values provided by the insurance companies. When the surrender values are higher, the fair value of investments in life insurance policies will be higher. As at 30 September 2021, if the surrender values have been 5% higher/lower, the impact on the amount attributable to the shareholders of the Group would be HK\$809,000 (31 March 2021: HK\$798,000) higher/lower, respectively.
  • ^^ The fair value of the investment in the convertible bond depends on the underlying share price of the issuer and the expected volatility of the share price. As at 30 September 2021, it is estimated that with all other variables held constant, if the volatility values have been 5% higher, the impact on the amount attributable to the shareholders of the Company would be HK\$89,000 higher, if the volatility values have been 5% lower, the impact on the amount attributable to the shareholders of the Group would be HK\$93,000 lower.
  • ^^^ The fair value of trade receivables stated at fair value through other comprehensive income is determined by using a discounted cash flow valuation model based on the market interest rates of instruments with similar terms and risks.

12 TRADE AND BILLS RECEIVABLES

The Group's trading terms with its customers are mainly on credit with terms of one month, extending up to four months for major customers.

Overdue balances are reviewed regularly by senior management. As at 30 September 2021, the Group had certain concentration of credit risk that might arise from the exposure to its five largest customers and the largest customer which accounted for approximately 54.9% (31 March 2021: 46.5%) and 17.6% (31 March 2021: 12.8%) of the Group's total trade receivables, respectively. The Group does not hold any collateral or other credit enhancements over these balances. Trade receivables are non-interest bearing.

Unaudited Audited
30 September 31 March
2021 2021
HK\$'000 HK\$'000
Trade receivables 186,500 168,084
Bills receivable 3,868 14,974
190,368 183,058

12 TRADE AND BILLS RECEIVABLES (Continued)

An ageing analysis of the trade and bills receivables based on the invoice date and net of loss allowance, is as follows:

Unaudited
30 September
2021
HK\$'000
Audited
31 March
2021
HK\$'000
Within 1 month 114,083 65,984
1 to 3 months 59,418 98,027
3 to 6 months 14,937 12,684
Over 6 months 1,930 6,363
190,368 183,058

13 TRADE PAYABLES

An ageing analysis of the trade payables as at the end of the reporting period, based on the invoice date, is as follows:

Unaudited Audited
30 September 31 March
2021 2021
HK\$'000 HK\$'000
Within 30 days 82,935 109,061
31 to 90 days 36,766 69,546
119,701 178,607

The trade payables are non-interest bearing and are normally settled on terms of one to two months.

14 SHARE OPTIONS

The fair value of the share options granted on 20 April 2021 was HK\$32,977,000 (2020: nil) which was estimated using a binomial option pricing model, taking into account the terms and conditions upon which the options were granted.

The contractual life of each option granted is 10 years. The fair value of the outstanding options granted was estimated using the following assumptions:

Dividend yield (%) 2.20%
Expected volatility (%) 106.26%
Historical volatility (%) 106.26%
Risk free interest rate (%) 1.39%
Exercise Multiple — Director 3.34
Exercise Multiple — Employee 2.86

The values of options are subject to (i) subjectivity and uncertainty relating to the assumptions to which such values are subject; and (ii) limitation of the model used to estimate such values.

When share options are exercised, the amount previously recognised in share options reserve will be transferred to share premium. When the share options are forfeited after the vesting date or are still not exercised at the expiry date, the amount previously recognised in share option reserve will be transferred to retained profits.

15 RELATED PARTY TRANSACTIONS

  • a In addition to the transactions detailed in elsewhere in these interim financial statements, the Group had the following transactions with related parties:
  • (i) The then shareholder of Pangaea (H.K.) Limited, Ample Chance International Limited, had guaranteed a bank loan made to the Group of HK\$27,300,000 at 31 March 2020.
  • (ii) Mr. Fung Yui Kong had undertaken to indemnify the Group for all costs, losses and/or expenses for any taxation of the Group incurred with respect to the transfer pricing arrangement that arose prior to the Listing.
Unaudited
For the six months ended
30 September
2021
2020
HK\$'000
HK\$'000
Short-term employee benefits
Post-employment benefits
Share based payment expenses
6,381
503
6,995
358
for share option 3,356
10,240

7,353

b Compensation of key management personnel of the Group:

16 COMMITMENTS

The Group leases certain of its office premises under short-term operating lease arrangements.

At the end of the reporting period, the Group had total future minimum lease payments under non-cancellable operating leases falling due as follows:

Unaudited Audited
30 September 31 March
2021 2021
HK\$'000 HK\$'000

Within one year 559 185